SynBiotic SE (ETR:SBX)
0.7960
-0.2500 (-23.90%)
Aug 14, 2026, 5:35 PM CET
SynBiotic SE Market Cap
SynBiotic SE has a market cap or net worth of €5.43 million as of August 14, 2026. Its market cap has decreased by -74.84% in one year.
Market Cap
5.43M
Enterprise Value
5.52M
Revenue
14.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.80
ChartMarket Cap Chart
Since January 7, 2021, SynBiotic SE's market cap has decreased from 49.05M to 5.43M, a decrease of -88.93%. That is a compound annual growth rate of -32.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 5.43M | -71.77% |
| Dec 30, 2025 | 19.24M | -32.82% |
| Dec 30, 2024 | 28.64M | 107.48% |
| Dec 29, 2023 | 13.81M | -64.07% |
| Dec 30, 2022 | 38.43M | -60.60% |
| Dec 30, 2021 | 97.53M | 98.83% |
| Jan 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 59.26B |
| Bayer Aktiengesellschaft | 46.95B |
| Siemens Healthineers AG | 43.76B |
| Fresenius SE & Co. KGaA | 26.99B |
| MeVis Medical Solutions AG | 42.95M |
| NanoRepro AG | 24.28M |
| aap Implantate AG | 22.12M |
| Maternus-Kliniken Aktiengesellschaft | 19.50M |